Spexis
Presence
Spexis is a company listed under the stock ticker POLN (CH).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Spexis
- Jeffrey Wager, Chairman of the Board and Chief Executive Officer
- Dennis Ausiello, Vice Chairman of the Board
- Bernard Bollag, Director
Popular executive movements at Spexis
- Hernan Levett, Chief Financial Officer, will leave the company on Dec. 1, 2023 (posted on November 1 2023).
- Martin Jakobovic who is Head of Finance, will be promoted to Interim Chief Financial Officer on Dec. 1, 2023 (posted on November 1 2023).
- Gonçalo Bernardes has joined the company as Acting Head of Chemical Biology (posted on September 29 2023).
Create your alert
to follow the executive moves at Spexis.
Pharmaceuticals
Spexis has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Spexis
Social media about Spexis
- Spexis on Wikipedia, Google News & Yahoo Finance
- Spexis on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Bernard Bollag 
